Illumina's EPS (Basic) for the
three
months ended in Mar. 2022 was $0.55.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2022 was $4.63.
Illumina's EPS without NRI for the
three
months ended in Mar. 2022 was $0.55.
Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2022 was $4.60.
During the past 12 months, Illumina's average EPS without NRIGrowth Rate was 7.50% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -3.20% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 7.00% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 24.60% per year.
During the past 13 years, Illumina's highest 3-Year average EPS without NRI Growth Rate was 56.40% per year. The lowest was -211.50% per year. And the median was 27.40% per year.
Illumina Earnings per Share (Diluted) Historical Data
The historical data trend for Illumina's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Illumina Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Earnings per Share (Diluted)
4.92
5.56
6.74
4.45
5.04
Illumina Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Earnings per Share (Diluted)
1.00
1.26
2.08
0.71
0.55
Competitive Comparison
For the Diagnostics & Research subindustry, Illumina's Earnings per Share (Diluted), along with its competitors' market caps and Earnings per Share (Diluted) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Illumina Earnings per Share (Diluted) Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Earnings per Share (Diluted) distribution charts can be found below:
* The bar in red indicates where Illumina's Earnings per Share (Diluted) falls into.
Illumina Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Illumina's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2021 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.60
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
Illumina (NAS:ILMN) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Illumina Earnings per Share (Diluted) Related Terms
Thank you for viewing the detailed overview of Illumina's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
6.68(3.62%) Volume: 1,118,137 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:ILMN has been successfully added to your 
